PUTRAJAYA, March 21 (Bernama) — Sponsored clinical research in Malaysia recorded an exceptional performance in 2021, surpassing its previous years accomplishments, as highlighted in Clinical Research Malaysia’s (CRM) Annual Report 2021. The report was launched earlier today by the Minister of Health, YB Khairy Jamaluddin at the Ministry of Health complex in Putrajaya, witnessed by CRM Board of Directors and stakeholders.
The annual report detailed 215 new sponsored clinical research in the country, the highest annual number reported since CRM’s inception. In 2021, Malaysia moved a position up, now ranking second within Southeast Asia region after Singapore, in terms of the number of global industry sponsored studies. These record-high numbers were also reflected in the Gross National Income generated, with highest annual value of RM 226 million investment reported from new sponsored studies, contributing to a cumulative value of RM 834 million generated from sponsored research since 2012.
- Thousands Protest In London Over Trump UK Visit
- Egypt Says Stolen Pharaoh’s Gold Bracelet Melted Down, Sold For 4,000 USD
- Palestinian Death Toll In Gaza Tops 65,000: Health Authorities
- Roundup: Civilian Lifelines Collapsing In Gaza City, UN Humanitarians Say
- Hezbollah Official, Civilian Killed In Israeli Airstrike In Eastern Lebanon
- Two Security Personnel Killed, 30 Injured In Suicide Attack In SW Pakistan
- Indonesian President Inaugurated New Ministers
- Only 13 Survived After Boat Carrying 74 Migrants Capsized Off Libya
- Putin, Modi Discussed Bilateral Ties, Ukraine In Phone Call
- Iran Executed Man Spying For Israel